Meaning of non‐overlapping patients between the MAFLD and NAFLD definitions-Reference-Cited by-同舟云学术

Meaning of non‐overlapping patients between the MAFLD and NAFLD definitions

Published:2022-01-29 Issue:2 Volume:42 Page:271-273
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Chan Wah‐Kheong¹^ORCID,Wong Vincent W.‐S.²^ORCID

Affiliation:

1. Gastroenterology and Hepatology Unit Department of Medicine Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

2. Department of Medicine and Therapeutics State Key Laboratory of Digestive Disease, and Medical Data Analytics Centre The Chinese University of Hong Kong Hong Kong Hong Kong

Funder

Chinese University of Hong Kong

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15142

Reference20 articles.

1. Non-alcoholic fatty liver disease

2. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

3. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

4. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B

5. Comparison of MAFLD and NAFLD diagnostic criteria in real world

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification prediction of metabolic fatty liver based on PMAFLD-TabNet;2024 International Conference on Electronic Engineering and Information Systems (EEISS);2024-01-13

2. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019;World Journal of Hepatology;2023-11-27

3. A systematic review on factors associated with non-alcoholic fatty liver disease (NAFLD) among adolescents;Clinical Nutrition ESPEN;2023-10

4. Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy;Hepatology International;2023-05-26

5. An international multidisciplinary consensus statement on MAFLD and the risk of CVD;Hepatology International;2023-05-19